{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:02:08Z","timestamp":1770138128282,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NHLBI Training in Academic Nephrology postdoctoral grant","award":["T32 DK007527"],"award-info":[{"award-number":["T32 DK007527"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Renin angiotensin aldosterone system inhibitors (RAASi) and diuretics are among the most frequently prescribed anti-hypertensives. Individuals with chronic kidney disease (CKD) are particularly at risk for electrolyte disturbances and kidney injury but the appropriate use of lab monitoring following RAASi or diuretic initiation is uncertain in CKD.<\/jats:p>\n            <jats:p>We describe the frequency and time interval of lab monitoring during initiation of RAASi and diuretics in CKD and assess whether close lab monitoring associates with one-year risk of emergency department (ED) visit or hospitalization.<\/jats:p>\n            <jats:p>We evaluated an observational cohort of 8,217 individuals with stage 3\u20135 non-dialysis CKD newly prescribed a RAASi (52.3%) or diuretic (47.7%) from thirty-six primary care offices affiliated with Brigham and Women's Hospital and Massachusetts General Hospital between 2009 and 2011.<\/jats:p>\n            <jats:p>Overall, 3306 (40.2%) individuals did not have pre-prescription labs done within 2 weeks, and 5957 (72.5%) did not have post-prescription labs done within 2 weeks which includes 524 (6.4%) individuals without post-prescription within 1 year. Close monitoring occurred in only 1547 (20.1%) and was more likely in individuals prescribed diuretics compared to RAASi (adjusted OR 1.39; 95%CI 1.20\u20131.62), with CKD stage 4,5 compared with stage 3 (adjusted OR 1.47; 95%CI 1.16\u20131.86) and with cardiovascular disease (adjusted OR 1.42; 95%CI 1.21\u20131.66). Close monitoring was not associated with decreased risk of ED visit or hospitalization.<\/jats:p>\n            <jats:p>Close lab monitoring during initiation of RAASi or diuretics was more common in participants with cardiovascular disease and advanced CKD suggesting physicians selected high-risk individuals for close monitoring. As nearly 80% of individuals did not receive close lab monitoring there may be value in future research on electronic physician decision tools targeted at lab monitoring.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017963","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T13:18:24Z","timestamp":1575551904000},"page":"e17963","source":"Crossref","is-referenced-by-count":2,"title":["Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease"],"prefix":"10.1097","volume":"98","author":[{"given":"Katherine G.","family":"Garlo","sequence":"first","affiliation":[{"name":"Department of Medicine, Renal Division"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Bates","sequence":"additional","affiliation":[{"name":"The Center for Patient Safety Research and Practice, Division of General Internal Medicine and Primary Care, Brigham & Women's Hospital, Boston"},{"name":"Clinical & Quality Analysis, Partners HealthCare, Somerville, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane L.","family":"Seger","sequence":"additional","affiliation":[{"name":"The Center for Patient Safety Research and Practice, Division of General Internal Medicine and Primary Care, Brigham & Women's Hospital, Boston"},{"name":"Clinical & Quality Analysis, Partners HealthCare, Somerville, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Fiskio","sequence":"additional","affiliation":[{"name":"The Center for Patient Safety Research and Practice, Division of General Internal Medicine and Primary Care, Brigham & Women's Hospital, Boston"},{"name":"Clinical & Quality Analysis, Partners HealthCare, Somerville, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Charytan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Renal Division"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,12]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/dom.12600","article-title":"Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial","volume":"18","author":"Heerspink","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"R4-20230915","first-page":"e479","article-title":"Focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the american college of cardiology Foundation\/American heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J Hypertens"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2369-15-200","article-title":"Understanding physicians\u2019 behavior toward alerts about nephrotoxic medications in outpatients: a cross-sectional analysis","volume":"15","author":"Insook","year":"2014","journal-title":"BMC Nephrol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","volume":"6","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/amiajnl-2013-001813","article-title":"Overrides of medication-related clinical decision support alerts in outpatients","volume":"21","author":"Nanji","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"(7.)","key":"R10-20230915","article-title":"Association of changes in creatinine and potassium levels after initiation of renin angiotensin aldosterone system inhibitors with emergency department visits, hospitalizations, and mortality in individuals with chronic kidney disease","volume":"1","author":"Garlo","year":"2018","journal-title":"JAMA Netw Open"},{"key":"R11-20230915","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor\u2013associated elevations in serum creatinine","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of competing risks in survival analysis","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2288-10-97","article-title":"Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes","volume":"10","author":"Lim","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/ndt\/gft355","article-title":"When do we need competing risks methods for survival analysis in nephrology?","volume":"28","author":"Noordzij","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cardfail.2007.11.008","article-title":"Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Lakhdar","year":"2008","journal-title":"J Card Fail"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-6-306","article-title":"Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study","volume":"6","author":"Espinel","year":"2013","journal-title":"BMC Res Notes"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinternmed.2009.284","article-title":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy","volume":"169","author":"Weinberg","year":"2009","journal-title":"Arch Intern Med"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/archinte.167.18.1930","article-title":"Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials","volume":"167","author":"Phillips","year":"2007","journal-title":"Arch Intern Med"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.kint.2016.09.038","article-title":"Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes","volume":"91","author":"Clase","year":"2017","journal-title":"Kidney Int"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"j791","DOI":"10.1136\/bmj.j791","article-title":"Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: Cohort study","volume":"356","author":"Schmidt","year":"2017","journal-title":"BMJ"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2016.16201","article-title":"US emergency department visits for outpatient adverse drug Events, 2013\u20132014","volume":"316","author":"Shehab","year":"2016","journal-title":"JAMA"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.07.022","article-title":"Use of clinical decision support systems for kidney-related drug prescribing: a systematic review","volume":"58","author":"Tawadrous","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.ajkd.2017.06.008","article-title":"Impact of electronic acute kidney injury (AKI) alerts with automated nephrologist consultation on detection and severity of AKI: a quality improvement study","volume":"71","author":"Park","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.286.22.2839","article-title":"Guided medication dosing for inpatients with renal insufficiency","volume":"286","author":"Chertow","year":"2001","journal-title":"JAMA"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijmedinf.2017.01.018","article-title":"User requirements for a chronic kidney disease clinical decision support tool to promote timely referral","volume":"101","author":"Gulla","year":"2017","journal-title":"Int J Med Inform"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jcjd.2017.08.244","article-title":"The effectiveness of pharmacist interventions on cardiovascular risk in adult patients with type 2 diabetes: the multicentre randomized controlled RxEACH trial","volume":"41","author":"Al Hamarneh","year":"2017","journal-title":"Can J Diabetes"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12911-016-0350-z","article-title":"Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: A mixed methods study","volume":"16","author":"Donald","year":"2016","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:41:14Z","timestamp":1694814074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"49","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017963","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}